Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    "APUDoma"
Show Display Options
Download search resultsDownload the search results for:
"APUDoma" (2 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Not yet recruiting 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors
Conditions: Neuroendocrine;   Neuroendocrine Tumor;   Neuroendocrine Cancer;   Neuroendocrine Carcinoma;   Carcinoid;   Carcinoid Tumor;   Islet Cell Tumor;   Apudoma
Intervention: Drug: 68Ga-DOTATATE will be given in tracer doses and injected intravenously to image tumors by Positron Emission Tomography.
2 Active, not recruiting 68Ga-DOTATATE PET Scan in Neuroendocrine Cancer
Condition: Neuroendocrine Carcinoma
Intervention: Drug: 68Ga-DOTATATE PET scan

Indicates status has not been verified in more than two years